Severe COVID-19 is defined as SARS-CoV-2 infection with hypoxemia, respiratory distress (respiratory rate >30), and/or severe pneumonia on imaging (>50% infiltrates). 46, 47 Patients with ...
Objectives To evaluate knowledge, attitudes and practices towards routine vaccination in the Lebanese population in the post-COVID-19 period, and to examine differences between COVID-19 vaccinated and ...
Simnotrelvir is an oral 3-chymotrypsin–like protease inhibitor that has been found to have in vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and potential efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results